Nanoengineering‐armed oncolytic viruses drive antitumor response: progress and challenges
2024 · MedComm · 6 citations
https://doi.org/10.1002/mco2.755
Y
Yifan Shen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
75
Citations
5
h-index
2
i10-index
Yifan Shen is an academic researcher from Tongji University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Cancer Immunotherapy and Biomarkers & Immune cells in cancer. The author has an h-index of 5, co-authored 9 publications.
ORCID: 0000-0002-6058-9676Papers by this author
worksNanostructured drug delivery systems for posterior segment eye diseases: Strategies to defy ocular barriers
2025 · BMEMat · 6 citations
https://doi.org/10.1002/bmm2.70016
[Anti-inflammatory mixture alleviates acute lung injury induced by sepsis in rats by modulating Beclin-1-mediated autophagy].
2024 · PubMed · 0 citations
https://doi.org/10.3760/cma.j.cn121430-20240523-00453
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat